Cargando…
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study
BACKGROUND: Extraskeletal myxoid chondrosarcoma (EMC) is a rare subgroup within soft tissue sarcomas. Its sensitivity to chemotherapy is reported to be low. METHODS: We retrospectively reviewed a series of 11 EMC patients treated as from 2001 within the Italian Rare Cancer Network (RCN) with anthrac...
Autores principales: | Stacchiotti, Silvia, Dagrada, Gian Paolo, Sanfilippo, Roberta, Negri, Tiziana, Vittimberga, Isabella, Ferrari, Stefano, Grosso, Federica, Apice, Gaetano, Tricomi, Marco, Colombo, Chiara, Gronchi, Alessandro, Dei Tos, Angelo P, Pilotti, Silvana, Casali, Paolo G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879193/ https://www.ncbi.nlm.nih.gov/pubmed/24345066 http://dx.doi.org/10.1186/2045-3329-3-16 |
Ejemplares similares
-
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
por: Stacchiotti, Silvia, et al.
Publicado: (2012) -
Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma
por: Urbini, Milena, et al.
Publicado: (2018) -
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas
por: Brenca, Monica, et al.
Publicado: (2019) -
Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management
por: Stacchiotti, Silvia, et al.
Publicado: (2020) -
Extraskeletal Myxoid Chondrosarcoma of the Orbit
por: Al-Osaily, Abdullah M., et al.
Publicado: (2016)